Bio-Thera Solutions Announces Commercialization and License Agreement for BAT1706, a Proposed Biosimilar Referencing Avastin® (Bevacizumab)
GUANGZHOU, China--(BUSINESS WIRE)--#Avastin--Bio-Thera Solutions, Ltd. (688177.SH) today announced that it has entered into a commercialization…